Clinical trials of drug for rheumatoid arthritis stopped20th May 2010
Clinical trials involving a drug called ocrelizumab in patients with rheumatoid arthritis have been halted after scientists analysed data and found that other available treatments provided more favourable results.
The drug had been the focus of four phase-III trials as part of a development programme by Roche and Biogen. Arthritis Research UK has expressed its disappointment that the ocrelizumab clinical research programme has had to be stopped but said it acknowledged that the potential risk of serious, possibly fatal, infections justified this action.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Clinical trials of drug for rheumatoid arthritis stopped
Author: Mark Nicholls
Article Id: 14931
Date Added: 20th May 2010